Medicine and Dentistry
Inpatient
100%
Patient
94%
Patient with Cancer
84%
Therapeutic Procedure
76%
Serum
76%
Cancer Tissue
76%
Folate Receptor 1
76%
Ovarian Cancer
76%
Disease Burden
76%
Basophil Cell
76%
Neoplasm
47%
Malignant Neoplasm
25%
Neoadjuvant Therapy
23%
Effector Cell
17%
Type I Hypersensitivity
17%
Blood
16%
Antibody
15%
Symptomatic Treatment
15%
Antifolate
15%
Immunoglobulin E
8%
Cell Surface
8%
Parasitic Disease
8%
Desensitization
8%
Cancer Therapy
8%
Granzyme B
8%
Association
8%
Tumor Microenvironment
8%
Allergy
8%
Attention
8%
Bacterial Infection
8%
Stimulus
8%
Virus Infection
8%
Allergic Disease
8%
Serositis
8%
Tissues
8%
Basophil Activation Test
8%
Assay
8%
Oncology
8%
Inflammatory Mediator
8%
Chemotherapeutic Agent
8%
Receptor Affinity
8%
Histamine
8%
Cytokine
8%
Gene Expression
8%
Drug
8%
Patient Monitoring
7%
Cytotoxicity Assay
7%
Cell Killing
7%
Survival Rate
7%
Treatment Response
7%
Immunology and Microbiology
Basophil Granulocyte
86%
Chondroitin Sulfate Proteoglycan
76%
Cancer Tissue
76%
Disease Burden
76%
Melanoma Antigen
76%
Immunoglobulin E Antibody
76%
Immunoglobulin E
66%
Immunity
35%
Xenograft
19%
Macrophage
19%
Immunotherapy
19%
Monocyte
19%
Tissues
18%
Antibody-Dependent Cell-Mediated Cytotoxicity
17%
Electric Potential
15%
Effector Cell
9%
Phenotype
9%
Mouse
9%
Gene
9%
Monoclonals
9%
Signal Transduction
9%
Immunocompetent Cell
9%
Prevalence
9%
Survival
9%
Antineoplastic Activity
9%
Fc Receptor
9%
Viral Disease
8%
Cell Surface
8%
Granzyme B
8%
Inflammation
8%
Gene Expression
8%
Mediator
8%
Histamine
8%
Allergy
8%
Association
8%
Cytokine
8%
Basophil Activation
8%
Attention
8%
Receptor Affinity
8%
Circulation
8%
Cell Killing
7%
Dose
7%
Survival Rate
7%
Staining
7%
Normal Human
7%
Monospecific Antibody
7%
Cancer Antibody
7%
Cell Membrane
7%
Adjuvant
7%
Tumor Volume
7%
Biochemistry, Genetics and Molecular Biology
Antibody
92%
Melanoma-Associated Antigen
76%
Immunoglobulin E
76%
Folate Receptor
76%
Chondroitin Sulfate Proteoglycan
76%
Disease Burden
76%
Monocyte
19%
Macrophage
19%
Antibody Dependent Cellular Cytotoxicity
17%
Antifolate
15%
Electric Potential
15%
Prospective Study
15%
Fc Receptor
9%
Immunocompetent Cell
9%
Phenotype
9%
Survival
9%
Signal Transduction
9%
Gene Signature
9%
Mouse
9%
Antineoplastic Activity
9%
Prevalence
9%
Cell Membrane
7%
Cell Killing
7%
Survival Rate
7%
Membrane
7%
Cytotoxicity Assay
7%
Tumor Volume
7%
Dose
7%
Staining
7%
Normal Human
7%